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1. Introduction 
A large number of structurally unrelated compounds 
are known to be chemotactic to neutrophils [11. The 
heterogeneity of these molecules as well as the lack 
of structural information on many of them has 
prevented any definitive statements as to the nature 
of the cellular events controlling the chemotactic 
response. Recent studies in our laboratories have 
shown that a series of synthetic @-formy di-, tri- 
and tetrapeptides possess specific structural features 
which are translatable in terms of a specific receptor 
site on the cell surface of the neutrophil [2]. 
Identical structure-activity relationships were 
found for peptide mediated release of fl-glucuronidase, 
lysozyme and chemotactic response. The most potent 
of these synthetic hemoattractants was @formyl. 
Met.Leu.Phe.OH which had E&,-values of 7 X 10-r’ 
North-Holland Publishing Company - Amsterdam 
M for chemotaxis and 2.4-2.6 X 10-i’ M for lyso- 
somal enzyme release [2]. To facilitate biochemical 
investigation of the mechanisms of chemotaxis and 
lysosomal enzyme release an intrinsically radiolabeled 
acyl tripeptide of high specific activity is required. An 
elegant synthetic pathway towards this end is catalytic 
dehalotritiation of an halogenated precursor peptide. 
Unfortunately in the case of F.Met.Leu.Phe.OH, 
the sulphur containing side-chain does pose problems 
not the least of which are catalyst poisoning [3] and 
desulfuration [4]. To circumvent asimilar problem 
in the synthesis of a high specific activity radiolabeled 
enkephalin, isosteric replacement of methionine by 
norleucine prove,d successful [5]. The isosteric acyl 
tripeptide F.Me.Leu.Phe.OH was synthesized and 
found to possess good activity (EDso 6.6 X lo-” M 
chemotaxis and 1 S-1.9 X 1 Om9 M lysosomal enzyme 
release). Therefore, we synthesized the chlorinated 
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analog F.Nle.Leu.Phe(Cl).OH and exchanged the ring 
chlorine atom with tritium (New England Nuclear 
customer service) to give fl-formyl.Nle.Leu. [p-tritio] -
Phe.OH. A specific binding assay has been developed 
using this radiolabeled peptide with rabbit neutrophils. 
Full details of this procedure are given in ref. [6]. 
2. Materials and methods 
2.1. Analytical methods 
Thin layer chromatography was performed on 
pre-coated Merck silica gel 60 F254 glass plates 
using the solvent system: 
(A) n-Butanol/water/acetic acid (6: 1: 1) 
(B) Chloroform/methanol/water/acetic acid
(60:30: 1:4) 
(C) Benzene/water/acetic acid (9: 1:9). 
Peptides were visualized by spraying the plates 
with ninhydrin and chlorine/o-tolidine r agents. 
Electrophoreses atpH 2 and pH 5 were carried 
out routinely on Whatman 3MM paper at 1000 V for 
60 min (Isco 490 power pack). Rotary evaporations 
were carried out in vacua at a bath temperature of‘ 
40°C unless otherwise stated. 
2.2. Chemistry 
Racemic p-chlorophenylalanine was trifluoro- 
acetylated [7] and incubated at 37’C with carboxy- 
peptidase A [8]. Optically pure Lp-chlorophenyl- 
alanine was obtained in good yield (71%); d.p. 
248-25O’C [ref. [9] 241-243’C]. A single spot was 
found by thin-layer chromatography Rfi 0.41; Rf3 0.28; 
RF 0.38. [01]$=23” (C 0.4, HzO) [ref. [9,10] -27.8” 
(C 0.4, HzO) and -23” (C 0.5, HzO)] .Microanalyses 
for C, H and N gave the expected results. The halo- 
genated amino acid eluted at 133 min under standard 
3 h run conditions on a Beckman 119C. 
2.3. Amino acid analyzer 
The free amino acid was protected by reaction 
with t-butyloxycarbonyl (t-Boc) azide [ 1 l] . A 
portion of the t-Boc-Lp-chlorophenylalanine was 
converted to its cesium salt and coupled to chloro- 
methylated Bio-Beads S-X-l resin using the method 
of Gisin [ 121. Peptides were synthesized by the 
Merrifield solid-phase method and were removed from 
the resin support by reaction with anhydrous hydrogen 
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fluoride in the presence of anisole [131. The free 
tripeptide H.Nle.Leu. Phe(Cl).OH was purified by 
100 transfers in a Craig-Post countercurrent distribu- 
tion apparatus using the solvent system n-butanol/ 
acetic acid/water, 4: 1: 5. The peptide was located by 
quantitative ninhydrin reaction and the contents of 
tubes 65-80 were pooled, evaporated in vacua and the 
residue dissolved in distilled water and lyophilized. 
The peptide migrated as a single band on electro- 
phoresis at pH 2 and pH 5 (ninhydrin; o-tolidinel 
chlorine visualization) and was homogeneous on 
thin-layer chromatography Rfi 0.63; Rp 0.39; Rg 
0.35. Formylation was performed using the method 
of Sheehan and Yang [ 141. The reaction mixture was 
diluted with 10 vol. water and lyophilized. Thin-layer 
chromatography indicated that the formylation was 
quantitative Rfi 0.79; RR 0.74; RF 0.64. The product 
was ninhydrin negative, o-tolidine positive and judged 
homogeneous. Amino acid analysis Me 1 .O, Leu 1.07, 
Phe(C1) 1.04. 
2.4. Dehalotn’tiation and chromatography 
Dehalotritiation was carried out by New England 
Nuclear as a customer service. The radiolabeled 
compound (14 Ci/mmol) was examined by thin-layer 
chromatography in solvent systems A, B and C using 
silica-gel plates. The plates were scanned using a 
Packard Radiochromatograph model 7201 scanner. 
Only one peak of radioactivity, which corresponded 
to the RF of cold marker peptide, could be detected. 
2.5. Biological assays 
Chemotaxis and lysosomal enzyme-releasing 
activity were measured as described previously [2]. 
3. Results and discussion 
Previous tudies have suggested the presence of a 
specific high affinity binding site (receptor ?) related 
to the chemotactic response of neutrophils [2]. The 
present study was undertaken to allow for more direct 
investigation of this site via synthesis of a high specific 
activity radiolabeled ligand. Application of this radio- 
labeled compound to the study of the chemotactic 
peptide receptor is described fully in ref. [6]. The 
IDSo given in table 1 is that concentration of cold 
peptide required to inhibit 50% of the binding of the 
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Table 1 
ED,, Concentrations (M)a 
Compound Chemotaxisb Lysosomal enzyme relea& 
Lysozyme p-Clucuronidase 
F-Met-Leu-Phed 7.0 f 1.7 x lo-” 2.4 * 0.31 x 10-r’ 2.6 i 0.32 x lo-“, 
F-Nle-Leu-Phe 6.6 f 1.2 x lo-l0 1.5 f 0.2 x lo-’ 1.9 f 0.2 x lo-’ 
F-Nle-Leu-Phe(C1) 2.8 * 0.6 x lo-’ 8.5 f 1.1 x lo-’ 8.8 f 1.5 x lo-’ 
a ED,, = Concentration of peptide to give 50% maximum chemotactic response or release -
data are the average of at least 4-5 individual experiments 
b Chemotaxis was measured in a Boyden Chember as described previously [ 2 ] 
c Lysosomal enzyme release was measured using cytocholasin B treated cells as described 
previously [ 21 
d Data taken from ref. [ 2 ] 
radioactive tracer F.Nle.Leu.Phe.OH. The synthetic 
route chosen precluded use of the most active peptide 
in the series because of the presence of a methionine 
residue. However, we were able to demonstrate hat 
isosteric replacement of the methionine with nor- 
leucine produced a peptide with excellent biological 
activity (table 1). The lack of the sulfur atom also 
made this peptide highly suitable for intrinsic label- 
ing by catalytic tritiation. Therefore, the p-chloro- 
phenylalanine analog was prepared by us and dehalo- 
tritiated as a customer service by New England 
Nuclear. The resulting product was highly labeled 
(14 Ci/mmol) and found to be homogeneous by 
thin-layer chromatography in solvent systems A, B 
and C (fig.1). The radioactive peak corresponded to
cold marker peptide in each system. Figure 2 demon- 
strates the close correlation between specific binding, 
chemotaxis and lysosomal enzyme activities of six 
analogs (plotted as the EDso). The linear regression 
equation relating specific binding (X) to chemotaxis 
(Y) is 
Y = (0.96) X - 0.86. 
For specific binding (X) and lysozyme activity (Y) 
Y = (0.95) X - 0.48. 
Finally the equation relating specific binding (X) to 
fl-glucuronidase activity (Y) is 
Y = (0.97) X - 0.27. 
The correlation coefficients in each case are > 0.99. 
The slope of each line is close to 1 .O indicating that 
each of the biological properties of the peptides is 
proportional linearly to 50% occupancy of available 
binding sites as determined in the specific binding 
assay. The lower concentration of peptide required 
------J+c 
d F 
Fig.1. Radiochromatogram scans of N-formyl-norleucine- 
leucyl- [ptritio]phenylalanine following thin-layer chromato- 
graphy carried out m systems A, B and C as described in 
Materials and methods. Scanning rate was 2.0 cm/mm. 
Linear ranges were 3 X 10’ cpm (A) and 1 X lo5 cpm (B and 
C) and time constants were 10 (A) and 3 (B and C). Radio- 
labeled load gave 60-90% of the full scale deflection in the 
linear range indicated. (0) Origin, (F) solvent front. 
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Fig.2. Correlation diagram for specific binding versus chemo- 
taxis (0). lysozyme release (e) and p-glucuronidase release 
(0). Data plotted as ED,, for 6 N-formyl trigeptides. (1) 
F-Met-Leu-Phe.OH, (2) F-Ethionlnyl-Leu-Phe.OH, 
(3) F-Norleucyl-Leu-Phe.OH, (4) F-Phe-Leu-Phe.OH, 
(5) F-Met-Leu-Arg.OH and (6) F-Gly-Leu-Phe.OH. 
to induce chemotaxis is of particular interest when 
one considers that the cells are responding to a con- 
centration gradient. 
It is interesting from a structure-activity point 
of view that the sulfur of the methionine side-chain 
is not absolutely essential for biological activity 
(table 1). It does, however, enhance activity as 
indicated by the fact that the norleucyl analog had 
only 10.6% the activity of the parent F.Met.Leu.Phe. 
OH in the chemotactic assay. Additional studies have 
been carried out to determine the structure-activity 
relationships in this position. Also worthy of note is 
the 4-6-fold decrease in activity of the halogenated 
peptide compared to the parent norleucine peptide. 
This latter observation might suggest hat the area of 
the receptor interacting with the aromatic ring is 
spatially restricted. It will be interesting to see if this 
area of the receptor can be further probed by other 
modifications of the phenylalanyl residue. 
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